CHERYL REEDUS: Open Payments
NPI 1922003938 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 41 payments from 7 companies in 2025. Trend: 2023 $840 · 2024 $487 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $289 |
| Novartis Pharmaceuticals Corporation | 17 | $246 |
| HEARTFLOW, INC. | 1 | $124 |
| PFIZER INC. | 5 | $95 |
| Inspire Medical Systems, Inc. | 2 | $57 |
| Amgen Inc. | 3 | $51 |
| Novo Nordisk Inc | 2 | $35 |
Products named: CAMZYOS, LEQVIO, FFRct, VYNDAQEL, INSPIRE, REPATHA, Wegovy, ELIQUIS.
Industry payments across GA — which companies pay providers there.
